A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
05/2011
05/26/2011	US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
05/26/2011	US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders
05/26/2011	US20110124554 Fibrosuppressant Biotherapeutics
05/26/2011	US20110123646 Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use
05/26/2011	US20110123610 Extended release compositions containing tolterodine and process for preparing the same
05/26/2011	US20110123604 Absorbent polymeric compositions with varying counterion content and their methods of preparation and use
05/26/2011	US20110123548 Compositions and methods for the treatment and diagnosis of immune disorders
05/26/2011	US20110123544 Human antibodies that bind human il-12 and methods for producing
05/26/2011	US20110123498 Mesenchymal stromal cell populations and methods of using same
05/25/2011	EP2325317A1 Receptor nucleic acids and polypeptides
05/25/2011	EP2325300A1 Desaturase genes and uses thereof
05/25/2011	EP2324861A1 In vivo use of water absorbent polymers
05/25/2011	EP2324851A1 Methods of administering anti-TNFalpha antibodies
05/25/2011	EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage
05/25/2011	EP2324827A1 Therapeutic agent for anca-related vasculitis
05/25/2011	EP2324058A1 Biological applications of steroid binding domains
05/25/2011	EP2324046A2 Tgr5 modulators and methods of use thereof
05/25/2011	EP2323967A2 Fesoterodine comprising a reduced amount of dehydroxyfesoterodine
05/25/2011	EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
05/25/2011	EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity
05/25/2011	EP1317454B1 Caspase inhibitors and uses thereof
05/25/2011	EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
05/25/2011	CN1871347B Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in
05/25/2011	CN102076660A Sulfonamide compound or salt thereof
05/25/2011	CN102070715A Human antibodies that bind human TNF alpha
05/25/2011	CN102068594A Chinese medicament for treating chronic prostatitis
05/25/2011	CN102068585A Chinese medicinal compound preparation for treating chronic nephritis and nephrotic syndromes
05/25/2011	CN102068571A Medicinal composition for treating urinary tract inflammation and preparation method thereof
05/25/2011	CN102068566A Quality control method for Yinchen Wudan pills for treating damp-heat jaundice
05/25/2011	CN102068539A External traditional Chinese medical powder for treating children enuresis
05/25/2011	CN102068532A Traditional Chinese medicine formula for treatment of renal colic caused by renal calculus
05/25/2011	CN102068529A Traditional Chinese medicine for treatment of prostatic hyperplasia
05/25/2011	CN102068479A Chinese medicinal composition for treating chronic urinary tract infection and preparation method thereof
05/25/2011	CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases
05/25/2011	CN102068426A New application of Ginkgolide B derivative in medicament preparation
05/25/2011	CN101653499B New application of peony blood stasis removing preparation in preparing medicaments for preventing or treating diabetic complication
05/25/2011	CN101445462B Method for preparing tolterodine and tartrate thereof
05/25/2011	CN101420946B Tamsulosin-containing percutaneous absorption type preparation
05/25/2011	CN101237870B Concomitant pharmaceutical agents and use thereof
05/25/2011	CN101204516B Peroral Chinese traditional medicine for lung-heat enuresis
05/25/2011	CN101185759B Anti-angiogene compositions and methods of use
05/25/2011	CN101182449B Tortoise penis kidney-tonifying wine
05/25/2011	CN101167862B Traditional Chinese medicine compound preparation for treating diabetes and nephrosis and preparing method thereof
05/25/2011	CN101128431B Novel quinoline derivatives as potassium ion channel openers
05/24/2011	US7947810 Kits for diagnosing a hypophosphatemic disorder
05/24/2011	US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
05/24/2011	US7947462 Methods for identifying Kremen polypeptide binding partners
05/24/2011	CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines
05/24/2011	CA2472821C Process for producing fused imidazole compound, and reformatsky reagent in stable form and process for producing the same
05/24/2011	CA2463626C Piperidine- and piperazineacetamines as 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
05/24/2011	CA2453901C Substituted 4-aminocyclohexanols
05/24/2011	CA2450467C Methods for modulating bladder function
05/24/2011	CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
05/24/2011	CA2439787C Nitrogen-based camptothecin derivatives
05/24/2011	CA2401604C Method of treating cancer with anti-neurotrophin agents
05/24/2011	CA2393710C Caspase inhibitors and uses thereof
05/24/2011	CA2229631C Gene therapy using ovine adenoviral vectors
05/19/2011	WO2011060065A2 Instillation of liposomal formulation of sirna and antisense oligonucleotides
05/19/2011	WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/19/2011	WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers
05/19/2011	WO2011057382A1 Spirocyclic piperidine derivatives useful as renin inhibitors
05/19/2011	WO2010138384A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
05/19/2011	WO2010138366A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
05/19/2011	WO2010130799A3 Method for impregnation with supercritical co2
05/19/2011	US20110119775 Hydrazide-containing cftr inhibitor compounds and uses thereof
05/19/2011	US20110118825 Anti-angiogenic compositions and methods of use
05/19/2011	US20110118357 Process for preparing o-desmethylvenlafaxine
05/19/2011	US20110118305 Compounds
05/19/2011	US20110118282 Soluble Guanylate Cyclase Activators
05/19/2011	US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
05/19/2011	US20110118248 Heteroaryl sulfonamides and CCR2/CCR9
05/19/2011	US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2
05/19/2011	US20110118223 Novel quinuclidine derivatives and medicinal compositions containing the same
05/19/2011	US20110118213 Compounds and methods for delivery of prostacyclin analogs
05/19/2011	US20110118201 Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed
05/19/2011	US20110117162 Isolated Renal Cells and Uses Thereof
05/19/2011	US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/19/2011	US20110117084 Vandetanib derivatives
05/19/2011	US20110117079 Therapeutic dll4 binding proteins
05/19/2011	US20110117064 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
05/19/2011	US20110117053 Method of modulating fibroblast accumulation or collagen deposition
05/19/2011	US20110117021 Fully human anti-vap-1 monoclonal antibodies
05/19/2011	US20110117017 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof
05/19/2011	CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/18/2011	EP2322929A1 Diagnostics, drug screening and treatment for cancer
05/18/2011	EP2322601A1 Method of collecting placental stem cells
05/18/2011	EP2322545A1 Analogues of GLP-1
05/18/2011	EP2322237A1 Bicarbonate-Based solutions for dialysis therapies
05/18/2011	EP2322236A1 Bicarbonate-based solutions for dialysis therapies
05/18/2011	EP2322198A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322197A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322196A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322195A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322194A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322174A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes
05/18/2011	EP2322170A1 Minimizing adverse experience associated with oxybutynin therapy
05/18/2011	EP2321296A1 Substituted 5-aminopyrazoles and use thereof
05/18/2011	EP2320896A2 Vinpocetine and eburnamonine derivatives for promoting bone growth
05/18/2011	CN102066421A Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-MSK) and atrial natriuretic protein (ANP) and uses in hypertension and acute kidney injury
05/18/2011	CN102066412A Treatment of diseases and conditions mediated by eicosanoids

1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 562